Found: 6
Select item for more details and to access through your institution.
The Role of the European Medicines Agency in the Safety Monitoring of COVID-19 Vaccines and Future Directions in Enhancing Vaccine Safety Globally.
- Published in:
- Drug Safety, 2024, v. 47, n. 5, p. 405, doi. 10.1007/s40264-024-01405-9
- By:
- Publication type:
- Article
Predicting the submission frequency of periodic safety update reports: development and application of the EURD tool.
- Published in:
- Frontiers in Medicine, 2024, p. 1, doi. 10.3389/fmed.2024.1299190
- By:
- Publication type:
- Article
Pre‐approval and post‐approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: A comparison with standard approved cancer drugs.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 5, p. 2169, doi. 10.1111/bcp.15141
- By:
- Publication type:
- Article
The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs.
- Published in:
- International Journal of Health Policy & Management, 2022, v. 11, n. 5, p. 642, doi. 10.34172/ijhpm.2020.198
- By:
- Publication type:
- Article
Impact of safety-related regulatory action on clinical practice: a systematic review.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Improving Pharmacotherapy After Myocardial Infarction by Group Academic Detailing Using Feedback Data on a Patient Level.
- Published in:
- Pharmacotherapy, 2006, v. 26, n. 2, p. 254, doi. 10.1592/phco.26.2.254
- By:
- Publication type:
- Article